Effect of endothelin-1 (1-31) on the renal resistance vessels

Journal of Medical Investigation

Volumn 50, Issue 1-2, 2003, Pages 87-94

  Ozawa, Yuichi ^a   Hasegawa, Toyoshi ^a   Tsuchiya, Koichiro ^a   Yoshizumi, Masanori ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Afferent arteriole; Efferent arteriole; ET 1; ET 1(1 31)

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1 [1-31]; ENDOTHELIN DERIVATIVE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; DRUG DERIVATIVE; ENDOTHELIN 1; ENDOTHELIN 1 (1 31); ENDOTHELIN A RECEPTOR; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN RECEPTOR; ENDOTHELIN-1 (1-31); ENDOTHELIN-CONVERTING ENZYME 1; ENZYME INHIBITOR; GLYCOPEPTIDE; METALLOPROTEINASE; OLIGOPEPTIDE; PEPTIDE FRAGMENT; PHOSPHORAMIDON; PIPERIDINE DERIVATIVE; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME INHIBITION; IN VITRO STUDY; KIDNEY BLOOD VESSEL; KIDNEY PERFUSION; MALE; MUSCLE CELL; NONHUMAN; PROTEIN FUNCTION; RABBIT; RENAL ARTERY; VASCULAR RESISTANCE; VASOCONSTRICTION; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; HUMAN; KIDNEY; PERFUSION; PHYSIOLOGY; SYNTHESIS; ULTRASTRUCTURE; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; ARTERIOLES; ASPARTIC ENDOPEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENZYME INHIBITORS; GLYCOPEPTIDES; HUMANS; KIDNEY; MALE; METALLOENDOPEPTIDASES; MUSCLE, SMOOTH, VASCULAR; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PERFUSION; PIPERIDINES; RABBITS; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0038439366     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
2. Shimada K, Takahashi M, Tanzawa K: Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 269: 18275-18278, 1994
3. Kishi F, Minami K, Okishima N, Murakami M, Mori S, Yano M, Niwa Y, Nakaya Y and Kido H: Novel 31-amino acid length endothelins cause constriction of vascular smooth muscle. Biochem Biophys Res Commun 248: 387-390, 1998
4. Goto K, Hama H, Kasuya Y.: Molecular pharmacology and pathophysiological significance of endothelin. Jpn J Pharmacol 72: 261-290, 1996
5. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-bernard LM, Mitchell KD.: Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996
6. Schulz E, Ruschitzka F, Lueders S, Heydebluth R, Schrader J, Muller GA.: Effects of endothelin on hemodynamics, prostaglandins, blood coagulation and renal function. Kidney Inter 47: 795-801, 1995
7. Arai M, Yoguchi A, Iso T, Takahashi T, Imai S, Murata K and Suzuki T: Endothelin-1 and its binding sites are upregulated in pressure overloaded cardiac hypertrophy. Am J Physiol 268: H2084-H2091, 1995
8. Chua BHL, Krebs CJ, Chua CC and Diglio CA: Endothelin stimulates protein synthesis in smooth muscle cells. Am J Physiol 262: E412-E416, 1992
9. Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y and Kido H: Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol 159, 1987-1992, 1997
10. Yoshizumi M, Kagami S, Suzaki Y, Tsuchiya K, Houchi H, Hisayama T, Fukui H, Tamaki T.: Effect of endothelin-1(1-31) on human mesangial cell proliferation. Jap J Pharmacol 84: 146-155, 2000
11. Okishima N, Hagiwara Y, Seito T, Yano M, and Kido H.: Specific sandwich-type enzyme immunoassays for smooth muscle constricting novel 31-amino acid endothelines. Biochem Biophys Res Commun 256: 1-5, 1999
12. Okishima N, Yoshizumi m, Tsuchiya K, Cui P, Kitamura H, Tamaki T, Kido H.: Determination of the levels of novel 31-amino acid endothelins and endothelins in human lungs. Life Sci 68: 2073-2080, 2001
13. Yoshizumi M, Kim S, Kagami S, Hamaguchi A, Tsuchiya K, Houchi H, Iwao H, Kido H, Tamaki T: Effect of endothelin-1(1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br J Pharmacol 125: 1019-1027, 1998
14. Cui P, Tani K, Kitamura H, Okumura Y, Yano M, Inui D, Tamaki T, Sone S, Kido H.: A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes. J. Leukoc Biol 70: 306-312, 2001
15. A receptor. Life Sci 50: 247-255, 1992
16. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, Yano M: Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91: 4892-4896, 1994
17. G-nitro-L-arginine on isolated afferent arterioles. Jap J Pharmacol 62: 231-237, 1993
18. Tamaki T, Kiyomoto K, He H, Tomohiro A, Nishiyama A, Aki Y, Kimura S, Abe Y.: Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney Inter 49: 722-729, 1996
19. Osgood RW, Patton M, Hanly MJ, Venkatachalam M, Reineck HJ, Stein JH.: In vitro perfusion of the isolated dog glomerulus. Am J Physiol 244: F349-F354, 1983
20. Ito S, Carretero O: An in vitro approach to the study of macula densa-mediated glomerular hemodynamics. Kidney Inter 38: 1206-1210, 1990
21. Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S.: Conversion of big endothelin-1 to endothelin-1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochem Biophys Res Commun 178: 899-905, 1991
22. Watanabe H, Miyazaki H, Kondoh M, Masuda Y, Kimura S, Yanagisawa M, Masaki T, Murakami K.: Two distinct types of endothelin receptors are present on chick cardiac membranes. Biochem Biophys Res Commun 161: 1252-1259, 1989
23. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348-22357, 1990
24. Miyazaki M, Takai S.: Local angiotensin II-generating system in vascular tissues: the role of chymase. Hypertens Res 24: 189-193, 2001
25. Yamada M, Ueda M, Naruko T, Tanabe S, Han YS, Ikura Y, Ogami M, Takai S, Miyazaki M.: Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Inter 59: 1374-1381, 2001
26. Yasuoka H, Yoshizumi M, Inui D, Okishima N, Houchi H, Kirima K, Oshita S, Kido H, Tamaki T.: Effect of endothelin-1(1-31) on intracellular free calcium in cultured human mesangial cells. Life Sci 65: 267-272, 1999
27. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M: ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473-485, 1994
28. Lanese DM, Yuan BH, McMurtry IF, Conger JD.: Comparative sensitivities of isolated rat renal arterioles to endothelin. Am J Physiol 263: F894-F899, 1992
29. Loutzenhiser R, Epstein M, Hayashi K, Horton C.: Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol 258: F61-F68, 1990
30. Edwards RM, Trizna W, Ohlstein EH.: Renal microvascular effects of endothelin. Am J Physiol 259: F217-F221, 1990
31. Bloom ITM, Bentley FR, Wilson MA, Garrison RN.: In vivo effects of endothelin on the renal microcirculation. J Surgical Res 54: 274-280, 1993
32. Inui D, Yoshizumi M, Suzaki Y, Kirima K, Tsuchiya K, Houchi H, Kagami S, Tamaki T.: Effect of endothelin-1(1-31) on p38 mitogen-activated protein kinase in cultured human mesangial cells. Life Sci 68: 635-645, 2000
33. Moe Kyaw, Yoshizumi M, Tsuchiya K, Kirima K, Suzaki Y, Abe S, Hasegawa T, Tamaki T,: Antioxidants inhibit endothelin-1(1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). Biochem Pharmacol 64: 1521-1531, 2002
34. i in human coronary artery smooth muscle cells. Eur J Pharmacol 348: 305-309, 1998
35. Kido H, Nakano A, Okishima N, Wakabayashi H, Kishi F, Nakaya Y, Yoshizumi M, Tamaki T.: Human chymase, an enzyme forming novel bioactive 31-amino acid length endothelins. Biol Chem 379: 885-891, 1988